Oral contraceptives, replacement oestrogens and the risk of rheumatoid arthritis. 1989

M Hernandez-Avila, and M H Liang, and W C Willett, and M J Stampfer, and G A Colditz, and B Rosner, and R W Chang, and C H Hennekens, and F E Speizer
Harvard Medical School, Harvard School of Public Health, Boston, Massachusetts.

UI MeSH Term Description Entries
D008593 Menopause The last menstrual period. Permanent cessation of menses (MENSTRUATION) is usually defined after 6 to 12 months of AMENORRHEA in a woman over 45 years of age. In the United States, menopause generally occurs in women between 48 and 55 years of age. Change of Life, Female
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D003278 Contraceptives, Oral, Hormonal Oral contraceptives which owe their effectiveness to hormonal preparations. Hormonal Oral Contraceptive,Hormonal Oral Contraceptive Agent,Contraceptive Agents, Estrogen,Contraceptive Agents, Oral, Hormonal,Hormonal Oral Contraceptive Agents,Oral Contraceptive Agents, Hormonal,Oral Contraceptives, Hormonal,Contraceptive, Hormonal Oral,Contraceptives, Hormonal Oral,Estrogen Contraceptive Agents,Hormonal Oral Contraceptives,Oral Contraceptive, Hormonal
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001172 Arthritis, Rheumatoid A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated. Rheumatoid Arthritis
D012307 Risk Factors An aspect of personal behavior or lifestyle, environmental exposure, inborn or inherited characteristic, which, based on epidemiological evidence, is known to be associated with a health-related condition considered important to prevent. Health Correlates,Risk Factor Scores,Risk Scores,Social Risk Factors,Population at Risk,Populations at Risk,Correlates, Health,Factor, Risk,Factor, Social Risk,Factors, Social Risk,Risk Factor,Risk Factor Score,Risk Factor, Social,Risk Factors, Social,Risk Score,Score, Risk,Score, Risk Factor,Social Risk Factor
D014481 United States A country in NORTH AMERICA between CANADA and MEXICO.
D015914 Estrogen Replacement Therapy The use of hormonal agents with estrogen-like activity in postmenopausal or other estrogen-deficient women to alleviate effects of hormone deficiency, such as vasomotor symptoms, DYSPAREUNIA, and progressive development of OSTEOPOROSIS. This may also include the use of progestational agents in combination therapy. Hormone Replacement Therapy, Post-Menopausal,Postmenopausal Hormone Replacement Therapy,Replacement Therapy, Estrogen,Estrogen Progestin Combination Therapy,Estrogen Progestin Replacement Therapy,Estrogen Replacement,Replacement, Estrogen,Therapy, Estrogen Replacement,Estrogen Replacement Therapies,Estrogen Replacements,Hormone Replacement Therapy, Post Menopausal,Replacement Therapies, Estrogen,Replacements, Estrogen,Therapies, Estrogen Replacement

Related Publications

M Hernandez-Avila, and M H Liang, and W C Willett, and M J Stampfer, and G A Colditz, and B Rosner, and R W Chang, and C H Hennekens, and F E Speizer
April 1978, Lancet (London, England),
M Hernandez-Avila, and M H Liang, and W C Willett, and M J Stampfer, and G A Colditz, and B Rosner, and R W Chang, and C H Hennekens, and F E Speizer
July 1983, Lancet (London, England),
M Hernandez-Avila, and M H Liang, and W C Willett, and M J Stampfer, and G A Colditz, and B Rosner, and R W Chang, and C H Hennekens, and F E Speizer
June 1983, Lancet (London, England),
M Hernandez-Avila, and M H Liang, and W C Willett, and M J Stampfer, and G A Colditz, and B Rosner, and R W Chang, and C H Hennekens, and F E Speizer
March 2003, Annals of the rheumatic diseases,
M Hernandez-Avila, and M H Liang, and W C Willett, and M J Stampfer, and G A Colditz, and B Rosner, and R W Chang, and C H Hennekens, and F E Speizer
January 1989, British journal of rheumatology,
M Hernandez-Avila, and M H Liang, and W C Willett, and M J Stampfer, and G A Colditz, and B Rosner, and R W Chang, and C H Hennekens, and F E Speizer
January 1989, Scandinavian journal of rheumatology. Supplement,
M Hernandez-Avila, and M H Liang, and W C Willett, and M J Stampfer, and G A Colditz, and B Rosner, and R W Chang, and C H Hennekens, and F E Speizer
January 2014, Therapeutics and clinical risk management,
M Hernandez-Avila, and M H Liang, and W C Willett, and M J Stampfer, and G A Colditz, and B Rosner, and R W Chang, and C H Hennekens, and F E Speizer
December 1969, Lancet (London, England),
M Hernandez-Avila, and M H Liang, and W C Willett, and M J Stampfer, and G A Colditz, and B Rosner, and R W Chang, and C H Hennekens, and F E Speizer
December 1969, British medical journal,
M Hernandez-Avila, and M H Liang, and W C Willett, and M J Stampfer, and G A Colditz, and B Rosner, and R W Chang, and C H Hennekens, and F E Speizer
February 2004, The Journal of rheumatology,
Copied contents to your clipboard!